Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)

( DrugBank: delta-9-tetrahydrocannabinol, Tetrahydrocannabinol, Cannabidiol / KEGG DRUG: Dronabinol, Dronabinol, Cannabidiol )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
8	ハンチントン病	1

8. ハンチントン病

臨床試験数 : 242 / 薬物数 : 205 - (DrugBank : 62) / 標的遺伝子数 : 85 - 標的パスウェイ数 : 159

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01502046 (ClinicalTrials.gov)	September 2011	29/12/2011	Neuroprotection by Cannabinoids in Huntington's Disease	A Double Blind, Randomized, Cross Over, Placebo Controlled Phase 2 Clinical Trial to Asses Neuroprot ...	Huntington's Disease	Drug: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD);Drug: Placebo	Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal	GW Pharmaceuticals Ltd.	Completed	18 Years	N/A	Both	25	Phase 2	Spain

First Previous1Next Last